The Phase 3 trial for VQW-765, announced on October 14, 2026, enrolled 546 adults with social anxiety disorder across approximately 30 trial sites in the United States

552c7ae14

Mental health

Supports emotional wellbeing and psychological resilience through digital tools or professional care access.

3 debates·795 claims·43 news stories

0